Login / Signup

An Overview of Genus Malachra L.-Ethnobotany, Phytochemistry, and Pharmacological Activity.

Leonor Cervantes-CeballosJorge Sánchez-HoyosFredys Sanchez-HoyosErick Torres-NiñoJairo Mercado-CamargoAmparo Echeverry-GómezKarick Jotty ArroyoEsther Del Olmo-FernándezHarold Gómez-Estrada
Published in: Plants (Basel, Switzerland) (2022)
The genus Malachra L. belongs to the family Malvaceae. It includes herbs or subshrubs of nine accepted species with approximately thirty synonyms, and it has been widely used in community folk medicine to treat health problems including inflammation, nasal obstruction, leishmaniasis, malaria, childbirth, kidney disorders, fever, respiratory tract diseases, among others. From the genus Malachra L., flavonoids, steroids, triterpenes, anthocyanins, leucoanthocyanins, saponins, carbohydrates, phenols, glycosides, and alkaloids have been isolated and identified. Some pharmacological reports have indicated that the genus has antidiarrheal, antiepileptic, antiulcerogenic, antioxidant, anticonvulsant, antiviral, anticancer, antibacterial, anthelmintic, and hepatoprotective properties. However, there have been limited studies of bioactive molecules with pharmacological and biological activities associated with Malachra alceifolia Jacq., Malachra capitata (L.) L.,  Malachra fasciata Jacq.,  Malachra radiata (L.) L., Malachra ruderalis Gürke.,  Malachra rudis Benth.,  Malachra helodes Mart.,  Malachra urens Poit. ex Ledeb. & Alderstam., and Malachra officinalis Klotzsch. In this review, we consider the conservation of these species to save the ancestral knowledge of their traditional use in populations, and their pharmacological potential for future studies in search of alternatives for solutions to diseases in humans and animals and tools for the design and search of potential bioactive compounds against infectious and non-infectious agents.
Keyphrases
  • protein kinase
  • healthcare
  • respiratory tract
  • mental health
  • oxidative stress
  • public health
  • human health
  • genetic diversity
  • case control
  • risk assessment
  • tissue engineering
  • chronic rhinosinusitis